Influence of run of river dams on floodplain sediments and carbon dynamics

Autor: Pearson, Adam J., Pizzuto, James E., Vargas, Rodrigo

Publikováno v: In Geoderma 15 June 2016 272:51-63

Using sitting as a component of job rotation strategies: Are lifting/lowering kinetics and kinematics altered following prolonged sitting

Autor: Howarth, Samuel J., Beach, Tyson A.C., Pearson, Adam J., Callaghan, Jack P.

Publikováno v: In Applied Ergonomics 2009 40(3):433-439

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition.

Autor: Zhang J; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK., Pearson AJ; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK., Sabherwal N; Division of Developmental Biology and Medicine, School of Medical Sciences, FBMH, University of Manchester, UK., Telfer BA; Division of Pharmacy and Optometry, School of Health Sciences, FBMH, University of Manchester, UK., Ali N; Manchester University NHS FT, Wythenshawe hospital, UK., Kan K; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK., Xu Q; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK., Zhang W; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK., Chen F; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK., Li S; Wellcome Centre for Cell-Matrix Research, School of Biological Sciences, FBMH, University of Manchester, UK., Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, and Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA., Risa-Ebrí B; Division of Pharmacy and Optometry, School of Health Sciences, FBMH, University of Manchester, UK., Finegan KG; Division of Pharmacy and Optometry, School of Health Sciences, FBMH, University of Manchester, UK., Cross MJ; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, UK., Giurisato E; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK.; Department of Biotechnology Chemistry and Pharmacy, University of Siena, Italy., Whitmarsh AJ; Division of Molecular and Cellular Function, School of Biological Sciences, FBMH, University of Manchester, UK., Tournier C; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health (FBMH), University of Manchester, UK.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Mar 10; Vol. 2 (3), pp. 131-145.